ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Protein synthesis studied in stem cells for the first time – Medical News Today

Medical News TodayA new breakthrough in stem cell research has occurred, thanks to scientists at the Children’s Medical Center Research Institute at UT Southwestern Medical Center in Dallas, Texas. The researchers claim that protein synthesis – an essential biological …Stem cell study opens door to undiscovered world of biologyPhys.OrgExperts stand by stem cell therapyTimes of … Continue reading

2014-03-10 Michael Zand NEWS

Japanese researcher backtracks on ‘breakthrough’ STAP cell research – GlobalPost

Japanese researcher backtracks on ‘breakthrough’ STAP cell researchGlobalPostTOKYO (Reuters) – A Japanese scientist called on Monday for withdrawing stem–cell research he had been involved in that had appeared to promise a new era of medical biology as doubts have arisen over the results. The research, described as … …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS

Co-author urges retraction of groundbreaking stem cell study – The Japan Times

Co-author urges retraction of groundbreaking stem cell studyThe Japan TimesA biology professor involved in discovering what was touted as a groundbreaking method for producing stem cells has told his co-authors their research paper should be retracted, the government-affiliated Riken institute said. Questions have been raised … …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS

Research and Markets: Global Stem Cell Umbilical Cord Blood (UCB) Market to … – The Herald | HeraldOnline.com (press release)

Research and Markets: Global Stem Cell Umbilical Cord Blood (UCB) Market to …The Herald | HeraldOnline.com (press release)The study observed that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $ 6.5 billion in 2012. Developments and approvals for novel cord blood stem cells … Continue reading

2014-03-10 Michael Zand NEWS

Research and Markets: Global Stem Cell Umbilical Cord Blood (UCB) Market to … – Business Wire (press release)

Research and Markets: Global Stem Cell Umbilical Cord Blood (UCB) Market to …Business Wire (press release)The study observed that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $ 6.5 billion in 2012. Developments and approvals for novel cord blood stem cells therapies is … Continue reading

2014-03-10 Michael Zand NEWS

Study On Stem Cells Opens Door To Undiscovered World Of Biology – RedOrbit

RedOrbitFor the first time, researchers have shown that an essential biological process known as protein synthesis can be studied in adult stem cells – something scientists have long struggled to accomplish. The groundbreaking findings from the Children’s … …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS

Regenestem and Global Stem Cells Group Announce Alliance With Eric Yalung … – PR Web (press release)

Regenestem and Global Stem Cells Group Announce Alliance With Eric Yalung …PR Web (press release)The planned, 22,000 square foot, state-of-the-art medical facility in Manila will focus on providing the latest stem cell-based anti-aging and cosmetic therapies available, eliminating the need for invasive surgery. Regenestem is collaborating with … and more …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS

Co-Author of Stem-Cell Paper Asks for Retraction – Wall Street Journal

Co-Author of Stem–Cell Paper Asks for RetractionWall Street JournalThe co-author of two breakthrough papers on making stem cells said Monday he had asked for the papers to be retracted, citing “crucial mistakes” in the research. The research has come under increased scrutiny in recent weeks. Some scientists have said …Riken to respond to doubts about … Continue reading

2014-03-10 Michael Zand NEWS
  • 1
  • …
  • 3,246
  • 3,247
  • 3,248
  • 3,249
  • 3,250
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.